Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CRSP

Stock Name	Crispr Therapeutics AG
Ticker	CRSP(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CH0334081137
LEI	506700O6IRRIQLT3W370

Show aggregate CRSP holdings

News associated with CRSP

Look Under The Hood: IYY Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-12 08:04:40
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 473 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Mitsubishi UFJ Asset Management Co. Ltd. raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,725 shares of the company’s stock after buying an additional 473 […] - 2025-08-15 04:46:59
Sum Up The Parts: ESML Could Be Worth $50: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-12 08:44:07
Arkadios Wealth Advisors Has $382,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Arkadios Wealth Advisors decreased its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,238 shares of the company’s stock after selling 923 shares during the period. Arkadios Wealth Advisors’ holdings in CRISPR Therapeutics […] - 2025-08-06 06:46:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Purchased by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 21.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 68,058 shares of the company’s stock after acquiring an additional 12,025 shares during the period. Envestnet […] - 2025-07-29 04:09:03
Bank of New York Mellon Corp Boosts Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): Bank of New York Mellon Corp increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,702 shares of the company’s stock after acquiring an additional 1,133 shares during […] - 2025-07-28 04:22:49
Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Private Advisor Group LLC increased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 27.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,418 shares of the company’s stock after buying an additional 23,382 shares during the quarter. […] - 2025-07-23 06:23:04
3 Monster Stocks in the Making to Buy Right Now: Key PointsCRISPR Therapeutics is still in its early growth stage. - 2025-07-21 01:07:00
3 Monster Stocks to Hold for the Next 10 Years: Key PointsOnline video game platform Roblox is different from any other platform. - 2025-07-17 06:51:00
Allworth Financial LP Has $393,000 Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Allworth Financial LP lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 23.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,560 shares of the company’s stock after selling 3,518 shares during the quarter. Allworth Financial LP’s holdings […] - 2025-07-15 06:16:47
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Lifted by Axxcess Wealth Management LLC: Axxcess Wealth Management LLC increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 10,309 shares of the company’s stock after acquiring an additional 393 shares during the period. Axxcess Wealth Management LLC’s holdings in CRISPR Therapeutics were worth […] - 2025-07-14 05:45:01
Traders Purchase Large Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP): CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors bought 10,886 call options on the company. This represents an increase of approximately 49% compared to the typical daily volume of 7,308 call options. CRISPR Therapeutics Trading Down 1.8% NASDAQ CRSP opened at $59.00 on […] - 2025-07-11 02:50:55
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at Needham & Company LLC: CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They presently have a $81.00 target price on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 34.82% from the stock’s […] - 2025-07-10 04:01:25
Vontobel Holding Ltd. Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Vontobel Holding Ltd. lessened its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,741 shares of the company’s stock after selling 2,327 shares during the quarter. Vontobel Holding Ltd.’s holdings […] - 2025-07-08 05:21:04
Spire Wealth Management Has $57,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Spire Wealth Management reduced its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,670 shares of the company’s stock after selling 300 shares during the period. Spire Wealth Management’s […] - 2025-07-02 04:46:55
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $69.53 Average Target Price from Analysts: Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have issued a buy recommendation on the company. […] - 2025-06-24 02:54:46
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Farther Finance Advisors LLC: Farther Finance Advisors LLC lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 46.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,626 shares of the company’s stock after purchasing an additional 1,792 […] - 2025-06-20 04:29:03
Analysts Expect JHSC To Hit $45: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-10 08:53:42
California State Teachers Retirement System Sells 689 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): California State Teachers Retirement System lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,742 shares of the company’s stock after selling 689 shares during the period. California State […] - 2025-06-06 05:06:55
The Best Stocks to Invest $1,000 in Right Now: Are you just as afraid of a market pullback right now as you are of missing out on upside? If so, you're not alone. This is a confusing environment for investors. Major names like Nvidia and Home Depot are sending mixed messages, while the market itself seems to be waiting for mo - 2025-06-03 05:30:00
Two Sigma Advisers LP Increases Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Two Sigma Advisers LP lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 50.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 84,800 shares of the company’s stock after acquiring an additional 28,400 shares during the period. Two Sigma Advisers LP’s holdings in CRISPR Therapeutics were worth $3,338,000 as of […] - 2025-05-27 05:30:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Moderate Buy” by Analysts: CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and ten have assigned a buy recommendation […] - 2025-05-27 03:06:46
Ameriprise Financial Inc. Has $8.07 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Ameriprise Financial Inc. lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 205,173 shares of the company’s stock after acquiring an additional 18,412 shares during the period. Ameriprise Financial Inc.’s holdings in CRISPR Therapeutics were worth $8,072,000 as of its most recent […] - 2025-05-22 04:35:07
5 Monster Stocks to Hold for the Next 10 Years: The professionals who manage Wall Street funds and cater to wealthy investors live and die by their quarterly performance. However, the individual investor can win the long game by focusing on what will matter the most years into the future. - 2025-05-20 05:30:00
BNP Paribas Financial Markets Has $3.27 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): BNP Paribas Financial Markets decreased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,994 shares of the company’s stock after selling 4,962 shares during the quarter. BNP […] - 2025-05-16 05:08:54
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Decreased by Mercer Global Advisors Inc. ADV: Mercer Global Advisors Inc. ADV lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 13.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,980 shares of the company’s stock after selling 1,598 shares during […] - 2025-05-15 05:10:56
Barclays Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $42.00: CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price target lowered by Barclays from $56.00 to $42.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also recently commented on the stock. Truist Financial boosted their price […] - 2025-05-12 05:46:49
3 Monster Stocks to Hold for the Next 10 Years: The best investments are often stocks of companies offering goods and services that are perpetually in demand. Think entertainment, healthcare, or more recently, some consumer technologies. Many of these stocks can be bought and held forever, since they dish out reasonably predic - 2025-05-10 06:12:00
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has momentum on her side. Her largest fund has soared nearly 30% since bottoming out l - 2025-05-08 12:22:00
Dimensional Fund Advisors LP Has $37.28 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Dimensional Fund Advisors LP boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 947,301 shares of the company’s stock after purchasing an additional 122,695 shares during the quarter. Dimensional […] - 2025-05-05 05:20:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CRSP holdings

Date	Number of CRSP Shares Held	Base Market Value of CRSP Shares	Local Market Value of CRSP Shares	Change in CRSP Shares Held	Change in CRSP Base Value	Current Price per CRSP Share Held	Previous Price per CRSP Share Held
2025-12-03 (Wednesday)	63,639	USD 3,563,148	USD 3,563,148	0	USD 280,648	USD 55.99	USD 51.58
2025-12-02 (Tuesday)	63,639	USD 3,282,500	USD 3,282,500	2,265	USD 80,618	USD 51.58	USD 52.17
2025-12-01 (Monday)	61,374	USD 3,201,882	USD 3,201,882	0	USD -79,786	USD 52.17	USD 53.47
2025-11-28 (Friday)	61,374	USD 3,281,668	USD 3,281,668	151	USD 18,482	USD 53.47	USD 53.3
2025-11-27 (Thursday)	61,223	USD 3,263,186	USD 3,263,186	0	USD 0	USD 53.3	USD 53.3
2025-11-26 (Wednesday)	61,223	USD 3,263,186	USD 3,263,186	453	USD 7,737	USD 53.3	USD 53.57
2025-11-25 (Tuesday)	60,770	USD 3,255,449	USD 3,255,449	755	USD 179,680	USD 53.57	USD 51.25
2025-11-24 (Monday)	60,015	USD 3,075,769	USD 3,075,769	151	USD 68,800	USD 51.25	USD 50.23
2025-11-21 (Friday)	59,864	USD 3,006,969	USD 3,006,969	0	USD 56,272	USD 50.23	USD 49.29
2025-11-20 (Thursday)	59,864	USD 2,950,697	USD 2,950,697	-604	USD -116,845	USD 49.29	USD 50.73
2025-11-19 (Wednesday)	60,468	USD 3,067,542	USD 3,067,542	151	USD -157,608	USD 50.73	USD 53.47
2025-11-18 (Tuesday)	60,317	USD 3,225,150	USD 3,225,150	906	USD -61,467	USD 53.47	USD 55.32
2025-11-17 (Monday)	59,411	USD 3,286,617	USD 3,286,617	302	USD 181,621	USD 55.32	USD 52.53

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRSP by Blackrock for IE00BDZVHG35

Show aggregate share trades of CRSP

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 2,265 53.030 51.244 51.423 USD 116,472 47.21
2025-11-28 BUY 151 54.000 51.500 51.750 USD 7,814 47.15
2025-11-26 BUY 453 53.780 52.300 52.448 USD 23,759 47.09
2025-11-26 BUY 453 53.780 52.300 52.448 USD 23,759 47.09
2025-11-25 BUY 755 53.890 49.970 50.362 USD 38,023 47.06
2025-11-24 BUY 151 51.500 49.350 49.565 USD 7,484 47.04
2025-11-20 SELL -604 53.200 48.240 48.736 USD -29,437 47.01 Loss of -1,043 on sale
2025-11-19 BUY 151 53.830 50.570 50.896 USD 7,685 46.99
2025-11-18 BUY 906 54.994 52.070 52.362 USD 47,440 46.96
2025-11-17 BUY 302 55.760 51.220 51.674 USD 15,606 46.91
2025-11-14 BUY 151 54.770 49.110 49.676 USD 7,501 46.88
2025-11-12 BUY 151 55.690 52.050 52.414 USD 7,915 46.83
2025-11-10 BUY 150 58.460 53.830 54.293 USD 8,144 46.75
2025-11-06 BUY 150 58.750 54.570 54.988 USD 8,248 46.65
2025-11-04 BUY 151 60.640 56.000 56.464 USD 8,526 46.54
2025-10-30 BUY 755 62.770 60.910 61.096 USD 46,127 46.27
2025-10-29 BUY 302 62.560 65.050 64.801 USD 19,570 46.18
2025-10-22 SELL -604 66.520 70.735 70.314 USD -42,469 45.60 Loss of -14,927 on sale
2025-10-20 BUY 302 73.970 74.430 74.384 USD 22,464 45.28
2025-10-17 BUY 754 69.150 69.565 69.524 USD 52,421 45.14
2025-10-15 BUY 1,200 71.820 73.090 72.963 USD 87,556 44.98
2025-10-03 BUY 1,043 67.740 73.950 73.329 USD 76,482 44.70
2025-10-02 BUY 149 72.820 72.950 72.937 USD 10,868 44.53
2025-09-30 BUY 298 64.810 66.290 66.142 USD 19,710 44.27
2025-09-26 BUY 298 61.670 61.690 61.688 USD 18,383 44.04
2025-09-25 BUY 298 60.320 61.160 61.076 USD 18,201 43.94
2025-09-18 BUY 149 62.940 63.100 63.084 USD 9,400 43.82
2025-09-17 BUY 447 59.070 61.754 61.486 USD 27,484 43.73
2025-07-17 SELL -298 55.090 56.200 56.089 USD -16,715 43.27 Loss of -3,821 on sale
2025-07-16 BUY 492 55.140 55.330 55.311 USD 27,213 43.19
2025-07-11 SELL -1,184 56.800 59.480 59.212 USD -70,107 42.95 Loss of -19,258 on sale
2025-07-02 BUY 8,140 51.670 52.285 52.223 USD 425,099 42.60
2025-06-25 BUY 296 47.660 48.480 48.398 USD 14,326 42.46
2025-06-20 BUY 1,526 44.250 45.140 45.051 USD 68,748 42.39
2025-06-11 BUY 286 41.520 43.750 43.527 USD 12,449 42.39
2025-06-10 BUY 286 42.940 45.139 44.919 USD 12,847 42.38
2025-06-04 SELL -143 38.050 38.880 38.797 USD -5,548 42.45 Profit of 523 on sale
2025-04-23 BUY 143 38.540 40.730 40.511 USD 5,793 44.05
2025-04-10 SELL -1,144 34.260 34.770 34.719 USD -39,719 44.66 Profit of 11,374 on sale
2025-04-08 SELL -143 31.270 35.380 34.969 USD -5,001 44.93 Profit of 1,424 on sale
2025-04-07 SELL -143 32.380 34.216 34.032 USD -4,867 45.07 Profit of 1,579 on sale
2025-04-04 SELL -715 32.650 32.990 32.956 USD -23,564 45.22 Profit of 8,769 on sale
2025-04-01 BUY 1,260 33.140 34.930 34.751 USD 43,786 45.50
2025-03-31 SELL -423 34.030 35.750 35.578 USD -15,049 45.64 Profit of 4,255 on sale
2025-03-21 BUY 2,034 41.220 41.680 41.634 USD 84,684 46.10
2025-03-14 SELL -2,144 42.120 43.480 43.344 USD -92,930 46.40 Profit of 6,551 on sale
2025-03-07 SELL -268 45.530 45.790 45.764 USD -12,265 46.63 Profit of 232 on sale
2025-03-04 SELL -134 43.450 44.320 44.233 USD -5,927 46.78 Profit of 341 on sale
2025-02-25 BUY 268 44.510 46.670 46.454 USD 12,450 47.04
2025-02-19 SELL -134 53.020 55.880 55.594 USD -7,450 46.86 Loss of -1,171 on sale
2025-02-13 BUY 402 43.490 44.140 44.075 USD 17,718 46.70
2025-02-12 BUY 134 43.300 44.200 44.110 USD 5,911 46.77
2025-02-11 BUY 536 39.620 39.720 39.710 USD 21,285 46.92
2024-12-30 SELL -5,058 38.650 39.670 39.568 USD -200,135 49.50 Profit of 50,258 on sale
2024-11-18 SELL -2,205 47.300 48.280 48.182 USD -106,241 49.22 Profit of 2,285 on sale
2024-11-08 SELL -147 51.620 52.520 52.430 USD -7,707 48.94 Loss of -513 on sale
2024-10-21 SELL -148 48.510 48.940 48.897 USD -7,237 0.00 Loss of -7,237 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	2,265	53.030	51.244	51.423	USD 116,472	47.21
2025-11-28	BUY	151	54.000	51.500	51.750	USD 7,814	47.15
2025-11-26	BUY	453	53.780	52.300	52.448	USD 23,759	47.09
2025-11-26	BUY	453	53.780	52.300	52.448	USD 23,759	47.09
2025-11-25	BUY	755	53.890	49.970	50.362	USD 38,023	47.06
2025-11-24	BUY	151	51.500	49.350	49.565	USD 7,484	47.04
2025-11-20	SELL	-604	53.200	48.240	48.736	USD -29,437	47.01 Loss of -1,043 on sale
2025-11-19	BUY	151	53.830	50.570	50.896	USD 7,685	46.99
2025-11-18	BUY	906	54.994	52.070	52.362	USD 47,440	46.96
2025-11-17	BUY	302	55.760	51.220	51.674	USD 15,606	46.91
2025-11-14	BUY	151	54.770	49.110	49.676	USD 7,501	46.88
2025-11-12	BUY	151	55.690	52.050	52.414	USD 7,915	46.83
2025-11-10	BUY	150	58.460	53.830	54.293	USD 8,144	46.75
2025-11-06	BUY	150	58.750	54.570	54.988	USD 8,248	46.65
2025-11-04	BUY	151	60.640	56.000	56.464	USD 8,526	46.54
2025-10-30	BUY	755	62.770	60.910	61.096	USD 46,127	46.27
2025-10-29	BUY	302	62.560	65.050	64.801	USD 19,570	46.18
2025-10-22	SELL	-604	66.520	70.735	70.314	USD -42,469	45.60 Loss of -14,927 on sale
2025-10-20	BUY	302	73.970	74.430	74.384	USD 22,464	45.28
2025-10-17	BUY	754	69.150	69.565	69.524	USD 52,421	45.14
2025-10-15	BUY	1,200	71.820	73.090	72.963	USD 87,556	44.98
2025-10-03	BUY	1,043	67.740	73.950	73.329	USD 76,482	44.70
2025-10-02	BUY	149	72.820	72.950	72.937	USD 10,868	44.53
2025-09-30	BUY	298	64.810	66.290	66.142	USD 19,710	44.27
2025-09-26	BUY	298	61.670	61.690	61.688	USD 18,383	44.04
2025-09-25	BUY	298	60.320	61.160	61.076	USD 18,201	43.94
2025-09-18	BUY	149	62.940	63.100	63.084	USD 9,400	43.82
2025-09-17	BUY	447	59.070	61.754	61.486	USD 27,484	43.73
2025-07-17	SELL	-298	55.090	56.200	56.089	USD -16,715	43.27 Loss of -3,821 on sale
2025-07-16	BUY	492	55.140	55.330	55.311	USD 27,213	43.19
2025-07-11	SELL	-1,184	56.800	59.480	59.212	USD -70,107	42.95 Loss of -19,258 on sale
2025-07-02	BUY	8,140	51.670	52.285	52.223	USD 425,099	42.60
2025-06-25	BUY	296	47.660	48.480	48.398	USD 14,326	42.46
2025-06-20	BUY	1,526	44.250	45.140	45.051	USD 68,748	42.39
2025-06-11	BUY	286	41.520	43.750	43.527	USD 12,449	42.39
2025-06-10	BUY	286	42.940	45.139	44.919	USD 12,847	42.38
2025-06-04	SELL	-143	38.050	38.880	38.797	USD -5,548	42.45 Profit of 523 on sale
2025-04-23	BUY	143	38.540	40.730	40.511	USD 5,793	44.05
2025-04-10	SELL	-1,144	34.260	34.770	34.719	USD -39,719	44.66 Profit of 11,374 on sale
2025-04-08	SELL	-143	31.270	35.380	34.969	USD -5,001	44.93 Profit of 1,424 on sale
2025-04-07	SELL	-143	32.380	34.216	34.032	USD -4,867	45.07 Profit of 1,579 on sale
2025-04-04	SELL	-715	32.650	32.990	32.956	USD -23,564	45.22 Profit of 8,769 on sale
2025-04-01	BUY	1,260	33.140	34.930	34.751	USD 43,786	45.50
2025-03-31	SELL	-423	34.030	35.750	35.578	USD -15,049	45.64 Profit of 4,255 on sale
2025-03-21	BUY	2,034	41.220	41.680	41.634	USD 84,684	46.10
2025-03-14	SELL	-2,144	42.120	43.480	43.344	USD -92,930	46.40 Profit of 6,551 on sale
2025-03-07	SELL	-268	45.530	45.790	45.764	USD -12,265	46.63 Profit of 232 on sale
2025-03-04	SELL	-134	43.450	44.320	44.233	USD -5,927	46.78 Profit of 341 on sale
2025-02-25	BUY	268	44.510	46.670	46.454	USD 12,450	47.04
2025-02-19	SELL	-134	53.020	55.880	55.594	USD -7,450	46.86 Loss of -1,171 on sale
2025-02-13	BUY	402	43.490	44.140	44.075	USD 17,718	46.70
2025-02-12	BUY	134	43.300	44.200	44.110	USD 5,911	46.77
2025-02-11	BUY	536	39.620	39.720	39.710	USD 21,285	46.92
2024-12-30	SELL	-5,058	38.650	39.670	39.568	USD -200,135	49.50 Profit of 50,258 on sale
2024-11-18	SELL	-2,205	47.300	48.280	48.182	USD -106,241	49.22 Profit of 2,285 on sale
2024-11-08	SELL	-147	51.620	52.520	52.430	USD -7,707	48.94 Loss of -513 on sale
2024-10-21	SELL	-148	48.510	48.940	48.897	USD -7,237	0.00 Loss of -7,237 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRSP

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	953,115	4,329	1,561,113	61.1%
2025-09-18	785,585	8,069	1,220,457	64.4%
2025-09-17	969,121	4,953	1,279,724	75.7%
2025-09-16	717,696	9,117	1,297,125	55.3%
2025-09-15	563,632	479	919,636	61.3%
2025-09-12	474,757	434	740,276	64.1%
2025-09-11	514,524	2,730	952,484	54.0%
2025-09-10	332,259	613	508,092	65.4%
2025-09-09	499,735	309	750,774	66.6%
2025-09-08	359,910	19,558	639,197	56.3%
2025-09-05	505,860	3,428	1,468,732	34.4%
2025-09-04	422,391	282	1,377,451	30.7%
2025-09-03	409,382	185	711,844	57.5%
2025-09-02	441,840	754	719,669	61.4%
2025-08-29	356,063	1,032	642,325	55.4%
2025-08-28	384,593	4,175	619,959	62.0%
2025-08-27	474,604	413	707,409	67.1%
2025-08-26	337,801	1,235	504,210	67.0%
2025-08-25	341,566	592	535,909	63.7%
2025-08-22	432,311	1,060	750,307	57.6%
2025-08-21	276,384	525	494,439	55.9%
2025-08-20	481,035	2,447	863,226	55.7%
2025-08-19	927,248	8,194	1,463,449	63.4%
2025-08-18	615,097	9,049	934,759	65.8%
2025-08-15	954,882	10,702	1,464,721	65.2%
2025-08-14	1,089,392	1,036	1,635,553	66.6%
2025-08-13	1,486,679	7,827	2,362,627	62.9%
2025-08-12	691,845	70	906,264	76.3%
2025-08-11	532,884	1,847	848,363	62.8%
2025-08-08	465,426	7,018	715,834	65.0%
2025-08-07	619,867	41,404	892,222	69.5%
2025-08-06	732,619	52,416	1,122,409	65.3%
2025-08-05	1,326,117	68,326	1,979,716	67.0%
2025-08-04	954,133	2,820	1,308,605	72.9%
2025-08-01	942,950	1,553	1,336,174	70.6%
2025-07-31	761,454	2,945	1,160,135	65.6%
2025-07-30	798,189	7,689	1,224,483	65.2%
2025-07-29	1,040,522	8,025	1,845,442	56.4%
2025-07-28	381,215	1,024	710,369	53.7%
2025-07-25	712,035	1,807	1,285,840	55.4%
2025-07-24	895,784	5,505	1,297,746	69.0%
2025-07-23	1,105,981	71,388	1,837,178	60.2%
2025-07-22	1,078,815	8,858	1,753,952	61.5%
2025-07-21	1,982,720	46,367	3,377,746	58.7%
2025-07-18	2,862,091	13,877	5,362,030	53.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE